chr12-112504549-G-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_002834.5(PTPN11):c.1713-146G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0619 in 664,276 control chromosomes in the GnomAD database, including 8,595 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
 Genomes: 𝑓 0.056   (  1313   hom.,  cov: 33) 
 Exomes 𝑓:  0.063   (  7282   hom.  ) 
Consequence
 PTPN11
NM_002834.5 intron
NM_002834.5 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.698  
Publications
9 publications found 
Genes affected
 PTPN11  (HGNC:9644):  (protein tyrosine phosphatase non-receptor type 11) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains two tandem Src homology-2 domains, which function as phospho-tyrosine binding domains and mediate the interaction of this PTP with its substrates. This PTP is widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration. Mutations in this gene are a cause of Noonan syndrome as well as acute myeloid leukemia. [provided by RefSeq, Aug 2016] 
PTPN11 Gene-Disease associations (from GenCC):
- LEOPARD syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia
- Noonan syndrome with multiple lentiginesInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- metachondromatosisInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- cardiofaciocutaneous syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- Costello syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87). 
BP6
Variant 12-112504549-G-A is Benign according to our data. Variant chr12-112504549-G-A is described in ClinVar as Benign. ClinVar VariationId is 1293594.Status of the report is criteria_provided_single_submitter, 1 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.597  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| PTPN11 | NM_002834.5 | c.1713-146G>A | intron_variant | Intron 14 of 15 | ENST00000351677.7 | NP_002825.3 | ||
| PTPN11 | NM_001330437.2 | c.1725-146G>A | intron_variant | Intron 14 of 15 | NP_001317366.1 | |||
| PTPN11 | NM_001374625.1 | c.1710-146G>A | intron_variant | Intron 14 of 15 | NP_001361554.1 | |||
| PTPN11 | XM_011538613.3 | c.1722-146G>A | intron_variant | Intron 14 of 15 | XP_011536915.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0565  AC: 8593AN: 152132Hom.:  1318  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
8593
AN: 
152132
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.0634  AC: 32488AN: 512026Hom.:  7282   AF XY:  0.0620  AC XY: 17033AN XY: 274666 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
32488
AN: 
512026
Hom.: 
 AF XY: 
AC XY: 
17033
AN XY: 
274666
show subpopulations 
African (AFR) 
 AF: 
AC: 
716
AN: 
13582
American (AMR) 
 AF: 
AC: 
5137
AN: 
26386
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
84
AN: 
16822
East Asian (EAS) 
 AF: 
AC: 
19585
AN: 
30456
South Asian (SAS) 
 AF: 
AC: 
4230
AN: 
53980
European-Finnish (FIN) 
 AF: 
AC: 
148
AN: 
44178
Middle Eastern (MID) 
 AF: 
AC: 
65
AN: 
2164
European-Non Finnish (NFE) 
 AF: 
AC: 
1019
AN: 
296788
Other (OTH) 
 AF: 
AC: 
1504
AN: 
27670
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.509 
Heterozygous variant carriers
 0 
 862 
 1724 
 2587 
 3449 
 4311 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 246 
 492 
 738 
 984 
 1230 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0565  AC: 8598AN: 152250Hom.:  1313  Cov.: 33 AF XY:  0.0630  AC XY: 4688AN XY: 74438 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
8598
AN: 
152250
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
4688
AN XY: 
74438
show subpopulations 
African (AFR) 
 AF: 
AC: 
2340
AN: 
41550
American (AMR) 
 AF: 
AC: 
2201
AN: 
15282
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
19
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
3179
AN: 
5172
South Asian (SAS) 
 AF: 
AC: 
468
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
23
AN: 
10622
Middle Eastern (MID) 
 AF: 
AC: 
15
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
219
AN: 
68016
Other (OTH) 
 AF: 
AC: 
134
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.498 
Heterozygous variant carriers
 0 
 302 
 604 
 906 
 1208 
 1510 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 88 
 176 
 264 
 352 
 440 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
848
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.